{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:27:42Z","timestamp":1785252462043,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070672"],"award-info":[{"award-number":["32070672"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32370718"],"award-info":[{"award-number":["32370718"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Outstanding Youth Foundation of Heilongjiang Province of China","award":["YQ2022C034"],"award-info":[{"award-number":["YQ2022C034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06872-x","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T04:41:01Z","timestamp":1753418461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ImmuProgML: machine learning-based dissection of cancer-immune dynamics during tumor progression to improve immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Hanxiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4079-8945","authenticated-orcid":false,"given":"Shangwei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"6872_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrd.2016.233","volume":"16","author":"WJ Lesterhuis","year":"2017","unstructured":"Lesterhuis WJ, Bosco A, Millward MJ, Small M, Nowak AK, Lake RA. Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity. Nat Rev Drug Discov. 2017;16:264\u201372.","journal-title":"Nat Rev Drug Discov"},{"key":"6872_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/srep00342","volume":"2","author":"L Chen","year":"2012","unstructured":"Chen L, Liu R, Liu ZP, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep. 2012;2:342.","journal-title":"Sci Rep"},{"key":"6872_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fncel.2020.00283","volume":"14","author":"N Dehorter","year":"2020","unstructured":"Dehorter N, Del Pino I. Shifting developmental trajectories during critical periods of brain formation. Front Cell Neurosci. 2020;14:283.","journal-title":"Front Cell Neurosci"},{"key":"6872_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12967-022-03445-0","volume":"20","author":"J Liu","year":"2022","unstructured":"Liu J, Ding D, Zhong J, Liu R. Identifying the critical states and dynamic network biomarkers of cancers based on network entropy. J Transl Med. 2022;20:254.","journal-title":"J Transl Med"},{"key":"6872_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1158\/0008-5472.CAN-19-2732","volume":"80","author":"JT George","year":"2020","unstructured":"George JT, Levine H. Sustained coevolution in a stochastic model of cancer-immune interaction. Cancer Res. 2020;80:811\u20139.","journal-title":"Cancer Res"},{"key":"6872_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.61186\/ijbc.16.2.84","volume":"16","author":"SA Aghapour","year":"2024","unstructured":"Aghapour SA, Torabizadeh M, Bahreiny SS, Saki N, Jalali Far MA, Yousefi-Avarvand A, Dost Mohammad Ghasemi K, Aghaei M, Abolhasani MM, Sharifani MS, et al. Investigating the dynamic interplay between cellular immunity and tumor cells in the fight against cancer: an updated comprehensive review. Iran J Blood Cancer. 2024;16:84\u2013101.","journal-title":"Iran J Blood Cancer."},{"key":"6872_CR7","first-page":"371","volume":"84","author":"PM Dimberu","year":"2011","unstructured":"Dimberu PM, Leonhardt RM. Cancer immunotherapy takes a multi-faceted approach to kick the immune system into gear. Yale J Biol Med. 2011;84:371\u201380.","journal-title":"Yale J Biol Med"},{"key":"6872_CR8","first-page":"452","volume":"42","author":"CL Ventola","year":"2017","unstructured":"Ventola CL. Cancer immunotherapy, part 2: efficacy, safety, and other clinical considerations. P T. 2017;42:452\u201363.","journal-title":"P T"},{"key":"6872_CR9","doi-asserted-by":"publisher","first-page":"e002032","DOI":"10.1136\/jitc-2020-002032","volume":"9","author":"JHA Creemers","year":"2021","unstructured":"Creemers JHA, Lesterhuis WJ, Mehra N, Gerritsen WR, Figdor CG, de Vries IJM, Textor J. A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery. J Immunother Cancer. 2021;9:e002032.","journal-title":"J Immunother Cancer"},{"key":"6872_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke JJ, Flaherty KT, Ribas A, Long GV. Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017;14:463\u201382.","journal-title":"Nat Rev Clin Oncol"},{"key":"6872_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40257-019-00475-1","volume":"21","author":"EM Rizk","year":"2020","unstructured":"Rizk EM, Seffens AM, Trager MH, Moore MR, Geskin LJ, Gartrell-Corrado RD, Wong W, Saenger YM. Biomarkers predictive of survival and response to immune checkpoint inhibitors in melanoma. Am J Clin Dermatol. 2020;21:1\u201311.","journal-title":"Am J Clin Dermatol"},{"key":"6872_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-025-00738-6","volume":"13","author":"H Soleimani Samarkhazan","year":"2025","unstructured":"Soleimani Samarkhazan H, Zehtabcheh S, Seraji HR, Beqaj SH, Tayefeh S, Mohammadi MH, Aghaei M. Unveiling the potential of CLL-1: a promising target for AML therapy. Biomark Res. 2025;13:28.","journal-title":"Biomark Res"},{"key":"6872_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13409","volume":"56","author":"N Zhang","year":"2023","unstructured":"Zhang N, Zhang H, Liu Z, Dai Z, Wu W, Zhou R, Li S, Wang Z, Liang X, Wen J, et al. An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms. Cell Prolif. 2023;56: e13409.","journal-title":"Cell Prolif"},{"key":"6872_CR14","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200267","volume":"10","author":"T van der Wal","year":"2020","unstructured":"van der Wal T, van Amerongen R. Walking the tight wire between cell adhesion and WNT signalling: a balancing act for beta-catenin. Open Biol. 2020;10: 200267.","journal-title":"Open Biol"},{"key":"6872_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/978-0-387-77574-6_13","volume":"624","author":"K Rass","year":"2008","unstructured":"Rass K, Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:162\u201378.","journal-title":"Adv Exp Med Biol"},{"key":"6872_CR16","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/jid.2013.72","volume":"133","author":"S Emmert","year":"2013","unstructured":"Emmert S, Kraemer KH. Do not underestimate nucleotide excision repair: it predicts not only melanoma risk but also survival outcome. J Invest Dermatol. 2013;133:1713\u20137.","journal-title":"J Invest Dermatol"},{"key":"6872_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20:651\u201368.","journal-title":"Nat Rev Immunol"},{"key":"6872_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.trecan.2016.10.010","volume":"2","author":"GJ Yuen","year":"2016","unstructured":"Yuen GJ, Demissie E, Pillai S. B lymphocytes and cancer: a love-hate relationship. Trends Cancer. 2016;2:747\u201357.","journal-title":"Trends Cancer"},{"key":"6872_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.csbj.2022.11.037","volume":"21","author":"L Zhang","year":"2023","unstructured":"Zhang L, Fan S, Vera J, Lai X. A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer. Comput Struct Biotechnol J. 2023;21:34\u201345.","journal-title":"Comput Struct Biotechnol J"},{"key":"6872_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/sj.bjc.6605214","volume":"101","author":"LL Chen","year":"2009","unstructured":"Chen LL, Blumm N, Christakis NA, Barabasi AL, Deisboeck TS. Cancer metastasis networks and the prediction of progression patterns. Br J Cancer. 2009;101:749\u201358.","journal-title":"Br J Cancer"},{"key":"6872_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106969","volume":"159","author":"Y Su","year":"2023","unstructured":"Su Y, Wu J, Li X, Li J, Zhao X, Pan B, Huang J, Kong Q, Han J. DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19. Comput Biol Med. 2023;159: 106969.","journal-title":"Comput Biol Med"},{"key":"6872_CR22","first-page":"741","volume":"9","author":"B Hoffner","year":"2018","unstructured":"Hoffner B, Benchich K. Trametinib: a targeted therapy in metastatic melanoma. J Adv Pract Oncol. 2018;9:741\u20135.","journal-title":"J Adv Pract Oncol"},{"key":"6872_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2217\/fon-2020-0023","volume":"16","author":"S Huijberts","year":"2020","unstructured":"Huijberts S, Wang L, de Oliveira RL, Rosing H, Nuijen B, Beijnen J, Bernards R, Schellens J, Wilgenhof S. Vorinostat in patients with resistant BRAF(V600E) mutated advanced melanoma: a proof of concept study. Future Oncol. 2020;16:619\u201329.","journal-title":"Future Oncol"},{"key":"6872_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.febslet.2007.12.014","volume":"582","author":"NM Mhaidat","year":"2008","unstructured":"Mhaidat NM, Thorne RF, de Bock CE, Zhang XD, Hersey P. Melanoma cell sensitivity to docetaxel-induced apoptosis is determined by class III beta-tubulin levels. FEBS Lett. 2008;582:267\u201372.","journal-title":"FEBS Lett"},{"key":"6872_CR25","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/bjd.14720","volume":"175","author":"AT McConnell","year":"2016","unstructured":"McConnell AT, Ellis R, Pathy B, Plummer R, Lovat PE, O\u2019Boyle G. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma. Br J Dermatol. 2016;175:1210\u201320.","journal-title":"Br J Dermatol"},{"key":"6872_CR26","doi-asserted-by":"publisher","first-page":"eade9944","DOI":"10.1126\/sciadv.ade9944","volume":"9","author":"CY Lin","year":"2023","unstructured":"Lin CY, Huang KY, Kao SH, Lin MS, Lin CC, Yang SC, Chung WC, Chang YH, Chein RJ, Yang PC. Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response. Sci Adv. 2023;9:eade9944.","journal-title":"Sci Adv"},{"key":"6872_CR27","doi-asserted-by":"publisher","first-page":"1024931","DOI":"10.3389\/fimmu.2022.1024931","volume":"13","author":"F Wang","year":"2022","unstructured":"Wang F, Zheng A, Zhang D, Zou T, Xiao M, Chen J, Wen B, Wen Q, Wu X, Li M, et al. Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma. Front Immunol. 2022;13:1024931.","journal-title":"Front Immunol"},{"key":"6872_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00008390-200404000-00002","volume":"14","author":"MM Lahn","year":"2004","unstructured":"Lahn MM, Sundell KL. The role of protein kinase C-alpha (PKC-alpha) in melanoma. Melanoma Res. 2004;14:85\u20139.","journal-title":"Melanoma Res"},{"key":"6872_CR29","first-page":"1904","volume":"27","author":"KS Liu","year":"2012","unstructured":"Liu KS, Ding WC, Wang SX, Liu Z, Xing GW, Wang Y, Wang YF. The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell growth in vitro and in vivo. Oncol Rep. 2012;27:1904\u201310.","journal-title":"Oncol Rep"},{"key":"6872_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000110","volume":"8","author":"J Sun","year":"2020","unstructured":"Sun J, Zhang Z, Bao S, Yan C, Hou P, Wu N, Su J, Xu L, Zhou M. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer. J Immunother Cancer. 2020;8: e000110.","journal-title":"J Immunother Cancer"},{"key":"6872_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41467-019-13983-9","volume":"11","author":"M Paczkowska","year":"2020","unstructured":"Paczkowska M, Barenboim J, Sintupisut N, Fox NS, Zhu H, Abd-Rabbo D, Mee MW, Boutros PC, Drivers P, Functional Interpretation Working G, et al. Integrative pathway enrichment analysis of multivariate omics data. Nat Commun. 2020;11:735.","journal-title":"Nat Commun"},{"key":"6872_CR32","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/nsr\/nwy162","volume":"6","author":"X Liu","year":"2019","unstructured":"Liu X, Chang X, Leng S, Tang H, Aihara K, Chen L. Detection for disease tipping points by landscape dynamic network biomarkers. Natl Sci Rev. 2019;6:775\u201385.","journal-title":"Natl Sci Rev"},{"key":"6872_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, Ye Z, Shen R, Yu G, Wu J, Xiong Y, Zhou R, Qiu W, Huang N, Sun L, et al. IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front Immunol. 2021;12: 687975.","journal-title":"Front Immunol"},{"key":"6872_CR34","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747\u201356.","journal-title":"Genome Res"},{"key":"6872_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/biomet\/asu009","volume":"101","author":"SD Zhao","year":"2014","unstructured":"Zhao SD, Cai TT, Li H. Direct estimation of differential networks. Biometrika. 2014;101:253\u201368.","journal-title":"Biometrika"},{"key":"6872_CR36","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/bioinformatics\/btab502","volume":"37","author":"JJ Tu","year":"2021","unstructured":"Tu JJ, Ou-Yang L, Zhu Y, Yan H, Qin H, Zhang XF. Differential network analysis by simultaneously considering changes in gene interactions and gene expression. Bioinformatics. 2021;37:4414\u201323.","journal-title":"Bioinformatics"},{"key":"6872_CR37","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/bioinformatics\/bti042","volume":"21","author":"I Yanai","year":"2005","unstructured":"Yanai I, Benjamin H, Shmoish M, Chalifa-Caspi V, Shklar M, Ophir R, Bar-Even A, Horn-Saban S, Safran M, Domany E, et al. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics. 2005;21:650\u20139.","journal-title":"Bioinformatics"},{"key":"6872_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/bioinformatics\/btp053","volume":"25","author":"DJ McCarthy","year":"2009","unstructured":"McCarthy DJ, Smyth GK. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics. 2009;25:765\u201371.","journal-title":"Bioinformatics"},{"key":"6872_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13073-022-01119-6","volume":"14","author":"H Liu","year":"2022","unstructured":"Liu H, Yuan M, Mitra R, Zhou X, Long M, Lei W, Zhou S, Huang YE, Hou F, Eischen CM, Jiang W. CTpathway: a CrossTalk-based pathway enrichment analysis method for cancer research. Genome Med. 2022;14:118.","journal-title":"Genome Med"},{"key":"6872_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002511","volume":"8","author":"C Winter","year":"2012","unstructured":"Winter C, Kristiansen G, Kersting S, Roy J, Aust D, Knosel T, Rummele P, Jahnke B, Hentrich V, Ruckert F, et al. Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol. 2012;8: e1002511.","journal-title":"PLoS Comput Biol"},{"key":"6872_CR41","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.7150\/thno.74281","volume":"12","author":"N Zhang","year":"2022","unstructured":"Zhang N, Zhang H, Wu W, Zhou R, Li S, Wang Z, Dai Z, Zhang L, Liu F, Liu Z, et al. Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma. Theranostics. 2022;12:5931\u201348.","journal-title":"Theranostics"},{"key":"6872_CR42","doi-asserted-by":"publisher","first-page":"bbac386","DOI":"10.1093\/bib\/bbac386","volume":"23","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhang N, Wu W, Zhou R, Li S, Wang Z, Dai Z, Zhang L, Liu Z, Zhang J, et al. Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma. Brief Bioinform. 2022;23:bbac386.","journal-title":"Brief Bioinform"},{"key":"6872_CR43","doi-asserted-by":"publisher","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"CJ Liu","year":"2023","unstructured":"Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y, Guo AY. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24:bbac558.","journal-title":"Brief Bioinform"},{"key":"6872_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma\u2019ayan A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform. 2013;14:128.","journal-title":"BMC Bioinform"},{"key":"6872_CR45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/17474086.2024.2391102","volume":"17","author":"Z Eftekhar","year":"2024","unstructured":"Eftekhar Z, Aghaei M, Saki N. DNA damage repair in megakaryopoiesis: molecular and clinical aspects. Expert Rev Hematol. 2024;17:705\u201312.","journal-title":"Expert Rev Hematol"},{"key":"6872_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70191","volume":"7","author":"M Torabizadeh","year":"2024","unstructured":"Torabizadeh M, Aghaei M, Saki N, Vahid MA, Bitaraf S, Bandar B. The association of nasal and blood eosinophils with serum IgE level in allergic rhinitis and asthma: a case-control study. Health Sci Rep. 2024;7: e70191.","journal-title":"Health Sci Rep"},{"key":"6872_CR47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11033-024-10200-9","volume":"52","author":"L Rajabi","year":"2025","unstructured":"Rajabi L, Ebrahimdoost M, Mohammadi SA, Soleimani Samarkhazan H, Khamisipour G, Aghaei M. Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53. Mol Biol Rep. 2025;52:102.","journal-title":"Mol Biol Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06872-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:25:45Z","timestamp":1757287545000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06872-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6872"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06872-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"826"}}